Publication
Cannabis’ legalization and what it means for regulatory regimes worldwide
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
Cannabis
Global | Publication | October 2020
Our global Food and Agribusiness team has a deep understanding of the existing and emerging issues surrounding the global cannabis industry. Cannabis is a sector in a state of rapid transition globally, as numerous countries and states have legalized its use for either recreational or medicinal purposes in recent years. This creates a myriad of opportunities and challenges for companies considering investment in the sector, particularly in relation to investments across multiple jurisdictions. Find out what’s new in this developing industry sector.
Thought leadership
Publication
Cashing out: What private producers and retailers should know and do when they receive an offer or find a buyer
The maturation of the cannabis sector is presenting an array of opportunities to private producers and retailers.
Publication
Canadian cannabis companies come under fire
In the 12 months leading to legalization in October 2018, Canadian public companies already in the medical cannabis space experienced “jaw-dropping growth” in their market capitalizations, notwithstanding that many reported negative earnings.
Publication
Agri-tech developments in the cannabis sector
The cannabis sector is a growing and exciting sector.
Senior Advisor
Email
keira.brennan@nortonrosefulbright.com
Head of Amsterdam
Email
saskia.blokland@nortonrosefulbright.com
Partner, Norton Rose Fulbright US Consultores em Direito Estrangeiro
Email
charles.johnson@nortonrosefulbright.com
Director: Global Head of Consumer Markets
Email
rosalind.lake@nortonrosefulbright.com
Partner
Email
joseph.williams@nortonrosefulbright.com
Recent publications
Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Country risk in unprecedented times: A precedent for cross-border loan documentation?
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .